Results 21 to 30 of about 29,732,513 (224)

Making Visible HTLV Infection in a Non-endemic Area of Argentina

open access: yesFrontiers in Medicine, 2022
In Argentina, the human T-cell lymphotropic virus type 1 (HTLV-1) infection has been documented mainly among blood banks with a prevalence of ~0.02–0.046% for Buenos Aires city, 0.8% for the northeast, and 1% for the northwest; both areas are considered ...
Federico R. Simioli   +7 more
doaj   +1 more source

HTLV-1 prevalence according to age for 386 female and 334 male community residents.

open access: yes, 2021
HTLV-1 infection was confirmed for 218 participants, using HTLV-1 western blots (WB) and/or HTLV-1 PCR (WB positive/PCR positive, 209; indeterminate WB/PCR positive, 8; tested by dried blood spot, PCR positive, 1).
Antoine Gessain (31917)   +7 more
core   +1 more source

Screening transplant donors for HTLV-1 and -2 [PDF]

open access: yes, 2016
Human T-cell leukemia virus-1 (HTLV-1) is the first pathogenic human retrovirus discovered in 1980.1 HTLV-1 causes 2 devastating diseases: adult T-cell leukemia/lymphoma (ATL) and a neurological disorder, HTLV-1–associated myelopathy/tropical spastic ...
Willems, Luc   +3 more
core   +1 more source

HTLV-1+ subject and uninfected volunteer samples used.

open access: yes, 2023
HTLV-1+ subject and uninfected volunteer samples used.
David S. Rueda (7879094)   +3 more
core   +1 more source

HTLV-1 and HIV/HTLV-1 prevalence distribution by sex and age class.

open access: yes, 2022
The figure shows the overall prevalence of infection by age group and the prevalence of infection by sex: A) In the HIV-1/HTLV-1 coinfected population; B) In the general population at the same place.
Jeanne Sica (686072)   +10 more
core   +1 more source

HTLV-1 infections [PDF]

open access: yesJournal of Clinical Pathology, 2000
Human T lymphotropic virus type 1 (HTLV-1) causes disabling and fatal diseases, yet there is no vaccine, no satisfactory treatment, and no means of assessing the risk of disease or prognosis in infected people. Recent research on the molecular virology and immunology of HTLV-1 shows the importance of the host's immune response in reducing the risk of ...
openaire   +2 more sources

The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases

open access: yesFrontiers in Microbiology, 2012
Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis in small subsets of HTLV-1-carriers.
Mari eKannagi   +4 more
doaj   +1 more source

Cost-effectiveness of human T-cell leukemia virus type 1 (HTLV-1) antenatal screening for prevention of mother-to-child transmission.

open access: yesPLoS Neglected Tropical Diseases, 2023
BackgroundHuman T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia-lymphoma (ATL) and HTLV-1-associated myelopathy-tropical spastic paraparesis (HAM/TSP) with a poor prognosis.
Akiko Kowada
doaj   +1 more source

No genetic evidence for involvement of Deltaretroviruses in adult patients with precursor and mature T-cell neoplasms [PDF]

open access: yes, 2007
Background The Deltaretrovirus genus comprises viruses that infect humans (HTLV), various simian species (STLV) and cattle (BLV). HTLV-I is the main causative agent in adult T-cell leukemia in endemic areas and some of the simian T-cell lymphotropic ...
Hummel, Michael   +9 more
core   +1 more source

Caracterização molecular do HTLV-1 em pacientes com paraparesia espástica tropical/mielopatia associada ao HTLV-1 em Belém, Pará Molecular characterization of HTLV-1 among patients with tropical spastic paraparesis/HTLV-1 associated myelopathy in Belém, Pará

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2006
O presente estudo avaliou a ocorrência da infecção pelo HTLV-1 e seus subtipos em amostras de sangue de pacientes com diagnóstico clínico de paraparesia espástica tropical/mielopatia associada ao Htlv-1.
Lucinda A. Souza   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy